Methyl (1S,3S,4R)-2-[(1R)-1-phenylethyl]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylate, 95%, 5g

Mevastatin>98.0%(HPLC)100mg

Ethyl 2-cyanothiazole-4-carboxylate, 97%, 100mg

4-(DIFLUOROMETHOXY)-3-FLUORO-1-NITROBENZENE, 95.0%, 1g

[1-(4-chlorophenyl)cyclopropyl]amine hydrochloride, 95.0%, 250mg

2,4-Dichloro-N-cyclopropyl-N-piperidin-4-ylmethyl-benzenesulfonamide hydrochloride, 95.0%, 100mg

4,6-difluoro-3H-imidazo[4,5-c]pyridine, 98%, 100mg

3-Bromo-5-(tert-butyl)-2-methoxybenzoic acid, 98%, 1g

4-(3,5-Dimethylisoxazol-4-yl)benzoic acid, 97.0%, 5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(pyridin-2-yl)propanoic acid, 95.0%, 10g

3-Amino-6-bromopyrazine-2-carbonitrile, 95.0%, 25g

150 mL Suprasil Nitrogen Dewar Flask, 1ea

Formiate de potassium, min 98 %, pour la synthèse, 250 g, emballage plastique.